ENTRY       D06747            Crude     Drug
NAME        Senega (JP18);
            Powdered senega (JP18);
            Senega (TN)
COMPONENT   (Senegin II [CPD:C08978] | Senegin III [CPD:C17760] | Senegin IV [CPD:C17761]), Methyl salicylate [CPD:C12305], Fatty oil, Polygalitol
SOURCE      Polygala senega [TAX:174549]
REMARK      Therapeutic category: 5100
            ATC code: R05CA06
            Chemical structure group: DG01067
            Product (DG01067): D06747<JP> D04326<JP>
EFFICACY    Expectorant
COMMENT     Major component: Senegin [CPD:C08978]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             R RESPIRATORY SYSTEM
              R05 COUGH AND COLD PREPARATIONS
               R05C EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS
                R05CA Expectorants
                 R05CA06 Senega
                  D06747  Senega (JP18) &lt;JP&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             5  Crude drugs and Chinese medicine formulations
              51  Crude drugs
               510  Crude drugs
                5100  Crude drugs
                 D06747  Senega (JP18); Powdered senega (JP18)
            Classification of Japanese OTC drugs [BR:br08313]
             Agents for respiratory organs
              26 Antitussives and expectorants
               D06747  Senega (JP18)
            Risk category of Japanese OTC drugs [BR:br08312]
             Third-class OTC drugs
              Crude drugs
               Senega
                D06747  Senega (JP18)
            Crude drugs [BR:br08305]
             Dicot plants: rosids
              Polygalaceae (milkwort family)
               D06747  Senega
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Crude drugs
              D06747  Senega
              D06747  Powdered senega
DBLINKS     PubChem: 47208398
///
